IMPROVED CONTROL OF CISPLATIN-INDUCED EMESIS WITH A METOCLOPRAMIDE-DEXAMETHASONE COMBINATION

被引：16

作者：

COGNETTI, F

PINNARO, P

CARLINI, P

CAPORALI, C

RUGGERI, EM

POLLERA, CF

机构：

来源：

关键词：

D O I：

10.1007/BF00269037

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：235 / 237

页数：3

共 13 条

[1] AAPRO MS, 1981, CANCER CHEMOTH PHARM, V7, P11
[2] BRUERA ED, 1983, CANCER TREAT REP, V67, P381
[3] RANDOMIZED OPEN CROSSOVER TRIAL BETWEEN METOCLOPRAMIDE (MCP) AND DEXAMETHAZONE (DXM) FOR THE PREVENTION OF CISPLATIN-INDUCED NAUSEA AND VOMITING
COGNETTI, F
PINNARO, P
CARLINI, P
CONTI, EM
CORTESE, M
POLLERA, CF
[J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (02): : 183 - 187
[4] THE ROLE OF PROSTAGLANDINS IN THE EXCESSIVE NAUSEA AND VOMITING AFTER INTRAVASCULAR CIS-PLATINUM THERAPY
CURRY, SL
RINE, J
WHITNEY, CW
NAHHAS, WA
MORTEL, R
DEMERS, LM
[J]. GYNECOLOGIC ONCOLOGY, 1981, 12 (01) : 89 - 91
[5] NEIDHART JA, 1981, CANCER-AM CANCER SOC, V47, P1439, DOI 10.1002/1097-0142(19810315)47:6<1439::AID-CNCR2820470633>3.0.CO
[6] 2-#
[7] NEIDHART JA, 1983, ANTIEMETICS CANCER C, P142
[8] PENTA J, 1983, ANTIEMETICS CANCER C, P53
[9] PEROUTKA SJ, 1982, LANCET, V1, P658
[10] SEIGEL LJ, 1981, ANN INTERN MED, V95, P325